SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-22-002217
Filing Date
2022-05-27
Accepted
2022-05-27 16:05:25
Documents
14
Period of Report
2022-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 36458
2 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 255708
  Complete submission text file 0001178913-22-002217.txt   534656

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20220527.xsd EX-101.SCH 4734
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20220527_def.xml EX-101.DEF 18406
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20220527_lab.xml EX-101.LAB 28719
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20220527_pre.xml EX-101.PRE 20642
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 6885
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 22977331
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences